105 These findings imply that oxidized POLG causes mtDNA mutation or depletion and in turn results in a variety of diseases
Previous studies indicate that IGF-I is a potent vasodilator[152], and that this effect may be partly mediated by increased NO release from the endothelium[153, 154]
Semaglutide acts on GLP-1 receptors to help regulate appetite, digestion, and blood sugar levels
(PubMed) Kieburtz K, McDermott M, Como P, et al
The Weight Loss Blend is ideal for patients who struggle with: Stubborn visceral fat Insulin resistance or metabolic syndrome Fatigue and poor mitochondrial function Gut permeability and chronic inflammation Post-injury weight gain or loss of muscle mass Perimenopausal or age-related fat accumulation It's especially helpful for: Midlife men and women with hormone imbalances Athletes recovering from injury Patients who have failed on GLP-1 medications alone Stacking with other fat loss peptides (e.g., CJC-1295/Ipamorelin , Tesamorelin , MOTS-c ) can yield further metabolic enhancement if appropriate